Boston Scientific Reports Global Disruption After Cybersecurity Incident
Boston Scientific reports a cyber incident disrupting global operations, limiting system access and affecting order processing and shipments.
Read original at benzingaStocks · News reference
Novo Nordisk today announced that the European Commission (EC) has granted marketing authorisation for Wegovy® pill (once-daily oral semaglutide 25 mg) for the treatment of adults with obesity (BMI ≥30 kg/m²) or
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Boston Scientific reports a cyber incident disrupting global operations, limiting system access and affecting order processing and shipments.
Read original at benzingaFor adults over the age of 55, including patients in Medicare's GLP-1 Bridge program, these lower costs translate into meaningful savings as early as 12 months into treatment. This is the first study of its kind in
Read original at benzingaHims & Hers CEO Andrew Dudum defends the firm against an FTC lawsuit, discusses dropping GLP-1 drug prices and reveals in-house AI plans.
Read original at benzingahttps://www.wsj.com/health/pharma/novo-nordisk-starts-testing-lower-doses-of-its-wegovy-weight-loss-pills-8896fec2
Read original at benzingahttps://www.wsj.com/politics/policy/cia-chiefs-surprise-moscow-trip-was-to-warn-russia-not-to-attack-nato-c2d997f3?
Read original at benzingahttps://kfgo.com/2026/08/27/poland-asks-eu-to-fine-meta-e250-million-urges-action-against-scams-and-false-ads/
Read original at benzinga